Updated FDA final guidance for the agency’s Breakthrough Devices Program is intended to clarify how the program applies to innovative medical devices that may address health inequities. The guidance also specifies that the program may be available for some nonaddictive medical products intended for the treatment of pain or addiction. The voluntary Breakthrough Devices Program... Read More